AstraZeneca Partners With Oracle to Use AI in Clinical Trials
The companies will use AI and real-world data to identify eligible trial patients and monitor safety signals, among other measures.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
AstraZeneca Partners With Oracle on AI Clinical Research
AstraZeneca said it is teaming up with Oracle to refine clinical research, using Oracle's artificial-intelligence, cloud and data capabilities.